SCHEMBL102065

SCHEMBL102065

Nc1cc(F)cc(Cl)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.48
IDO1 P14902 1/20 0.43
HSD17B10 Q99714 6/20 0.40
ALDH1A1 P00352 4/20 0.40
TSHR P16473 3/20 0.40
TTR P02766 1/20 0.40
CYP3A4 P08684 1/20 0.40
RECQL P46063 1/20 0.40
ACLY P53396 2/20 0.39
CA1 P00915 4/20 0.38
CA2 P00918 3/20 0.38
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
GAA P10253 3/20 0.38
HPGD P15428 3/20 0.37
MAPK1 P28482 2/20 0.37
ALOX15 P16050 3/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6267077 0.98 THRB (0.46) THRBIDO1HSD17B10ALDH1A1TSHR
SCHEMBL374815 0.82 HSD17B10 (0.58) THRBIDO1HSD17B10ALDH1A1TSHR
SCHEMBL4929798 0.75 GAA (0.41) ALDH1A1TSHRCYP3A4CA1CA2
SCHEMBL5399616 0.75 ERN1 (0.46) THRBIDO1HSD17B10ALDH1A1TSHR
SCHEMBL29674856 0.75 ALDH1A1 (0.43) ALDH1A1TSHRCYP3A4CA1CA2
SCHEMBL9387233 0.75 ALDH1A1 (0.43) ALDH1A1TSHRCYP3A4CA1CA2
SCHEMBL4704877 0.75 ALDH1A1 (0.43) ALDH1A1TSHRCYP3A4CA1CA2
SCHEMBL2253709 0.75 TSHR (0.65) THRBHSD17B10ALDH1A1TSHRTTR
SCHEMBL104581 0.75 ERN1 (0.46) IDO1ALDH1A1CA1CA12CA9
SCHEMBL2806380 0.75 TTR (0.65) THRBHSD17B10ALDH1A1TSHRTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619388-A1 CATHEPSIN L INHIBITORS Biofront Therapeutics (Beijing) Co., Ltd. (CN) 2025-09-24 EP disclosed
WO-2024140356-A1 CATHEPSIN L INHIBITORS BIOFRONT THERAPEUTICS (BEIJING) CO., LTD. (CN) 2024-07-04 WO disclosed
US-11858905-B1 Cathepsin L inhibitors BIOFRONT THERAPEUTICS (BEIJING) CO., LTD. (CN) 2024-01-02 US disclosed
CN-116589425-A Cathepsin L inhibitors 百放英库医药科技(北京)有限公司 2023-08-15 CN disclosed
US-8883826-B2 Alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMA SA (CH) 2014-11-11 US disclosed
US-8674106-B2 Alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMA SA (CH) 2014-03-18 US disclosed
US-20130178631-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2013-07-11 US disclosed
CN-102993084-A Alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMACEUTICALS SA 2013-03-27 CN disclosed
CN-101001846-B Alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMACEUTICALS SA 2012-11-07 CN disclosed
US-20120277237-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2012-11-01 US disclosed
CN-101001846-A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors ADDEX PHARMACEUTICALS SA (CH) 2007-07-18 CN disclosed
EP-1765795-A2 ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharmaceuticals SA (CH) 2007-03-28 EP disclosed
WO-2005123703-A2 ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMACEUTICALS SA (CH) 2005-12-29 WO disclosed
CN-1195753-C Fused benzene derivatives useful as herbicides ISHIHARA SANGYO KAISHA (JP) 2005-04-06 CN disclosed
US-20040029734-A1 Fused-benzene derivatives useful as herbicides ISHIHARA SANGYO KAISHA, LTD. 2004-02-12 US disclosed
US-6573218-B1 Defoliants containing such as uracil and 1,4-benzoxazole or benzthiazole moieties ISHIHARA SANGYO KAISHA, LTD. (JP) 2003-06-03 US disclosed
EP-1111993-A4 FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES ISHIHARA SANGYO KAISHA (JP) 2002-12-04 EP disclosed
CN-1325267-A Fused-benzene derivatives useful as herbicides ISHIHARA SANGYO KAISHA (JP) 2001-12-05 CN disclosed
EP-1111993-A1 FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES ISHIHARA SANGYO KAISHA, LTD. (JP) 2001-07-04 EP disclosed
WO-2000013508-A1 FUSED-BENZENE DERIVATIVES USEFUL AS HERBICIDES ISHIHARA SANGYO KAISHA, LTD. (JP) 2000-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178631-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM5, GRM1, GRM2 THRB 653/4885IDO1 3816/4885HSD17B10 1829/4885
US-20040029734-A1 Fused-benzene derivatives useful as herbicides DDT, NQO2, DHRS9 THRB 2092/4885IDO1 2382/4885HSD17B10 1963/4885
US-11858905-B1 Cathepsin L inhibitors CTSV, CTSL, CTSB THRB 4286/4885IDO1 2904/4885HSD17B10 3178/4885
US-20120277237-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM5, GRM1, GRM2 THRB 653/4885IDO1 3816/4885HSD17B10 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.